Table 1 Chracteristics of GN Patients by donor category
From: Increased glomerulonephritis recurrence after living related donation
| Â | Deceased | Related | Unrelated | Total | P value* |
|---|---|---|---|---|---|
GN Patients | 4956 | 1576 | 704 | 7236 | 0 |
Other Patients | 6201 | 1686 | 900 | 8787 | Â |
Total | 11157 | 3262 | 1604 | 16023 | Â |
GN patients | |||||
 Age (Mean, SD) | 45.2 (13.4) | 35.5 (13.7) | 49.4 (12)* | 43.6 (15.2) | <0.0001 |
GN Category | |||||
 FSGS | 671 (13.5) | 207 (13.1) | 97 (13.7) | 975 (13.4) | <0.0001 |
 IgA | 1552 (31.3) | 557 (35.3) | 284 (40.3) | 2393 (33) |  |
 MCGN | 260 (5.2) | 57 (3.6) | 31 (4.4) | 348 (4.8) |  |
 MN | 210 (4.2) | 71 (4.5) | 28 (3.9) | 309 (4.2) |  |
 Other GN | 2263 (45.6) | 684 (43.4) | 264 (37.5) | 3211 (44.3) |  |
Male Gender, n (%) | 3311 (66.8) | 994 (63) | 487 (69.1) | 4792 (66.2) | <0.005 |
Caucasian ethnicity, n (%) | 4003 (80.7) | 1283 (81.4) | 586 (83.2) | 5872 (81.1) | 0.0006 |
Graft Number, n (%) | |||||
 Primary | 4385 (88.4) | 1464 (92.8) | 626 (88.9) | 6475 (89.4) | <0.0001 |
 Secondary | 514 (10.3) | 100 (6.3) | 72 (10.2) | 686 (9.4) |  |
 Subsequent | 57 (1.1) | 12 (0.7) | 6 (0.8) | 75 (1) |  |
Diabetes, n (%) | 485 (9.7) | 62 (3.9) | 45 (6.3) | 592 (8.1) | <0.0001 |
Peak panel reactive antibodies (%), Median (IQR) | 5 (0–26) | 1 (0–10) | 0 (0–8) | 3 (0–20) | <0.001 |
Total ischaemic time (hrs), Median (IQR) | 14 (11–18) | 2 (1–3) | 2 (1–4) | 11 (3–16) | <0.001 |
Zero HLA mismatches, n(%) | 219 (4.4) | 280 (17.7) | 35 (4.9) | 534 (7.4%) | <0.0001 |